Key result
Cardiotrophin-1 rapidly lowers blood pressure and raises heart rate in hypertensive and normotensive rats.
Why the study?
The acute hemodynamic effects of cardiotrophin-1 and its relationship with plasma concentration in spontaneously hypertensive and normotensive rats were not well characterized.
CT-1 acutely lowers BP and raises HR similarly in SHR and WKY; leaves open hemodynamic relevance in human hypertension.
There is considerable evidence to indicate that humoral factors play an important role in the development of left ventricular hypertrophy. Cardiotrophin-1 (CT-1) is a cytokine that has been shown to induce cardiac hypertrophy in a dose-dependent manner. The aim of the present study was to investigate the acute effect of CT-1 on hemodynamic parameters in spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) and to study the relationship between the plasma concentration of CT-1 and its hemodynamic effect. Ten-week-old SHR and age-matched WKY were used. Blood pressure (BP), heart rate (HR) and plasma concentration of CT-1 were measured both before and for 60 min after intravenous bolus injection of human CT-1 (10 microg/kg). CT-1 injection significantly decreased BP and significantly increased HR in SHR and WKY. There were significant differences in BP and HR between the two groups at all time points after injection. The lowest BP, highest HR and maximal plasma concentrations of CT-1 were observed in both groups within 10 min after injection. However, after converting the values into the percentage change from their respective baselines, there were no significant differences between the two groups in BP or HR at any time point. There was also no significant difference between the two groups at any time point in the plasma concentration of CT-1. This study indicates that CT-1 decreases BP and increases HR in both SHR and WKY. The most obvious change occurred within 10 min after injection. However, there was no significant difference in the hypotensive effect of CT-1 on 10-week-old SHR and WKY.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2001) studied Hypertension. Human Cardiotrophin-1 (CT-1) vs. Baseline and Wistar Kyoto rats was evaluated on Blood pressure, heart rate, and plasma concentration of CT-1. Intravenous human Cardiotrophin-1 (10 microg/kg) significantly decreased blood pressure and increased heart rate within 10 minutes in both spontaneously hypertensive and Wistar Kyoto rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: